Comparison of clinical features and health manifestations in lean vs. obese Indian women with polycystic ovarian syndrome
Authors:
Open Access
- 1 January 2009
- journal article
- research article
- Published by Medknow in Journal of Human Reproductive Sciences
- Vol. 2 (1) , 12-7
Abstract
Aims: To study the prevalence of clinical manifestations in obese and lean polycystic ovarian syndrome (PCOS) women and their health hazards. Settings and Design: This prospective study was carried out in a tertiary care infertility clinic from 1.7.2005 till 31.12.2007. Materials and Methods: These women were diagnosed to have PCOS by the European Society of Human Reproduction and Embryology and the American Society of Reproductive Medicine, Rotterdam 2003 criteria. They were further divided into two groups according to their body mass index (BMI): Group A (n = 300), overweight and obese with BMI >23 and Group B (n = 150), normal weight and lean with BMI ≤23. Stastical Analysis and Results: The prevalence of menstrual irregularities [79.2% vs. 44%, P = 0.000, 95% confidence interval (CI) = 0.26-0.44)] and clinical hyperandrogenism (74.2% vs. 50.6%, P = 0.000, 95% CI=0.14-0.32) was signifi cantly higher in the obese group, whereas android central obesity (waist to hip ratio >0.85) was similar in both groups, irrespective of body weight (47.7% vs. 38%, P = 0.056, 95% CI=0.06 to +0.18). Comparative data of various health manifestations in lean vs. obese women with POCS [Table 4]. Of the health risk manifestations, hypertension occurred in both groups with a similar frequency (41% vs. 35.5%, P = 0.261, 95% CI=0.03 to +0.15). Group A showed an increased prevalence of IGT (25% vs. 10%, P = 0.000, 95% CI= 0.13-0.29) and type two diabetes mellitus (11.7% vs. 6%, P = 0.000, 95% CI= 0.13-0.29) as compared with group B. endometrial hyperplasia (EH) also showed an increase prevalence in Group A compared with Group B (5.6% vs. 2%, P = 0.055, 95% CI= 0.01-0.08), although not statistically significant. Conclusion: PCOS emerges as a clinically heterogeneous condition with increased prevalence of health risks such as hypertension, diabetes and EH. Of these, diabetes and EH appear to be more prevalent in the obese, putting them at a greater risk of morbid problems at a much younger age than the lean ones.Keywords
This publication has 24 references indexed in Scilit:
- Age-specific prevalence and risk associations for impaired glucose tolerance in urban southern Indian population.2003
- Prevalence and Predictors of Coronary Artery Calcification in Women with Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2003
- Altered Vascular Function in Young Women with Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2002
- Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndromeHuman Reproduction, 2001
- Polycystic Ovary Syndrome Is Associated With Endothelial DysfunctionCirculation, 2001
- Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS populationHuman Reproduction, 2001
- Comment on “Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome” 1The Journal of Clinical Endocrinology & Metabolism, 1999
- Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women1The Journal of Clinical Endocrinology & Metabolism, 1999
- Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance.The Journal of Clinical Endocrinology & Metabolism, 1992
- CHRONIC ANOVULATION SYNDROME AND ASSOCIATED NEOPLASIA1983